Who is sponsoring NCT04543240?

NCT04543240 is sponsored by Georgetown University.

What drugs are being tested in NCT04543240?

Interventions in NCT04543240: Integra™ dermal regeneration template.

What condition does NCT04543240 study?

NCT04543240 studies Wounds and Injuries.

Is NCT04543240 still recruiting?

NCT04543240 is currently status unknown. Last updated 11 September 2020.

Last reviewed 2020-09-11 · How we verify

NCT04543240

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bacterial Load for Integra™ in Operative Wounds

Status unknown Last updated 11 September 2020

What this trial tests

trial testing Integra™ dermal regeneration template in Wounds and Injuries in 54 participants. Status unknown.

Timeline

14 December 2017

Primary endpoint
1 January 2021

1 January 2021

Quick facts

Lead sponsor	Georgetown University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	54
Start date	14 December 2017
Primary completion	1 January 2021
Estimated completion	1 January 2021
Sites	1 location across United States

Drugs / interventions tested

Integra™ dermal regeneration template

Conditions studied

Wounds and Injuries — all drugs for Wounds and Injuries →

Sponsor

Georgetown University

Who can join

Adults 18 to 90, any sex, with Wounds and Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proportion of postoperative complications (infections, dehiscence, graft slough) after initial application of Integra™

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wounds and Injuries

Currently open trials in the same condition.

NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT05638581 — Trauma Resuscitation With Low-Titer Group O Whole Blood or Products · Phase 3 · recruiting
NCT05910567 — A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma · NA · recruiting
NCT06121661 — APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System · Phase 1 · recruiting

Other Georgetown University trials

Trials by the same sponsor.

NCT07228000 — Bundled Cancer Screening and Genetic Services Navigation · NA · not yet recruiting
NCT07128927 — Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors · NA · recruiting
NCT06046287 — Daratumumab for Polyneuropathy Associated With MGUS · Phase 2 · withdrawn
NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
NCT07105358 — Visual Plasticity Following Brain Lesions · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04543240 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Georgetown University
Last refreshed: 11 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04543240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing